{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["AYUSH", "COVID-19", "herbal", "intranasal", "prophylactic"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34721035", "DateRevised": {"Year": "2021", "Month": "11", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "10", "Day": "14"}], "Language": ["eng"], "ELocationID": ["746729", "10.3389/fphar.2021.746729"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "12", "PubDate": {"Year": "2021"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Effect of Prophylactic Use of Intranasal Oil Formulations in the Hamster Model of COVID-19.", "Pagination": {"StartPage": "746729", "MedlinePgn": "746729"}, "Abstract": {"AbstractText": ["Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection initiates with viral entry in the upper respiratory tract, leading to coronavirus disease 2019 (COVID-19). Severe COVID-19 is characterized by pulmonary pathologies associated with respiratory failure. Thus, therapeutics aimed at inhibiting the entry of the virus or its internalization in the upper respiratory tract are of interest. Herein, we report the prophylactic application of two intranasal formulations provided by the National Medicinal Plant Board (NMPB), Anu oil and til tailya, in the hamster model of SARS-CoV-2 infection. Prophylactic intra-nasal instillation of these oil formulations exhibited reduced viral load in lungs and resulted in reduced body weight loss and lung-pneumonitis. In line with reduced viral load, histopathological analysis revealed a reduction in lung pathology in the Anu oil group as compared to the control infected group. However, the til tailya group did not show a significant reduction in lung pathology. Furthermore, molecular analysis using mRNA expression profiling indicated reduced expression of pro-inflammatory cytokine genes, including Th1 and Th17 cytokines for both the intranasal formulations as a result of decreased viral load. Together, the prophylactic intranasal application of Anu oil seems to be useful in limiting both viral load and severity in SARS-CoV2 infection in the hamster model."], "CopyrightInformation": "Copyright \u00a9 2021 Rizvi, Tripathy, Sharma, Goswami, Srikanth, Sastry, Mani, Surjit, Awasthi and Dikshit."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immuno-biology Laboratory, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India."}], "LastName": "Rizvi", "ForeName": "Zaigham Abbas", "Initials": "ZA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immuno-biology Laboratory, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India."}], "LastName": "Tripathy", "ForeName": "Manas Ranjan", "Initials": "MR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India."}], "LastName": "Sharma", "ForeName": "Nishant", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immuno-biology Laboratory, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India."}], "LastName": "Goswami", "ForeName": "Sandeep", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "DG(I/C), Central Council for Ayurvedic Sciences, New Delhi, India."}], "LastName": "Srikanth", "ForeName": "N", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "CEO-National Medicinal Plants Board, Ministry of AYUSH, New Delhi, India."}], "LastName": "Sastry", "ForeName": "J L N", "Initials": "JLN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India."}], "LastName": "Mani", "ForeName": "Shailendra", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India."}], "LastName": "Surjit", "ForeName": "Milan", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Immuno-biology Laboratory, Infection and Immunology Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India."}], "LastName": "Awasthi", "ForeName": "Amit", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Non-communicable Disease Centre, Translational Health Science and Technology Institute, NCR-Biotech Science Cluster, Faridabad, India."}], "LastName": "Dikshit", "ForeName": "Madhu", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abdelalim A. A., Mohamady A. A., Elsayed R. A., Elawady M. A., Ghallab A. F. (2021). Corticosteroid Nasal spray for Recovery of Smell Sensation in COVID-19 Patients: A Randomized Controlled Trial. Am. J. Otolaryngol. 42, 102884. 10.1016/j.amjoto.2020.102884", "ArticleIdList": ["10.1016/j.amjoto.2020.102884", "PMC7836546", "33429174"]}, {"Citation": "Afrin L. B., Weinstock L. B., Molderings G. J. (2020). Covid-19 Hyperinflammation and post-Covid-19 Illness May Be Rooted in Mast Cell Activation Syndrome. Int. J. Infect. Dis. 100, 327\u2013332. 10.1016/j.ijid.2020.09.016", "ArticleIdList": ["10.1016/j.ijid.2020.09.016", "PMC7529115", "32920235"]}, {"Citation": "Banerjee S., Kar A., Mukherjee P. K., Haldar P. K., Sharma N., Katiyar C. K. (2020). Immunoprotective Potential of Ayurvedic Herb Kalmegh (Andrographis Paniculata) against Respiratory Viral Infections - LC-MS/MS and Network Pharmacology Analysis. Phytochem. Anal. 32, 629\u2013639. 10.1002/pca.3011", "ArticleIdList": ["10.1002/pca.3011", "33167083"]}, {"Citation": "Bao L., Deng W., Huang B., Gao H., Liu J., Ren L., et al. (2020). The Pathogenicity of SARS-CoV-2 in hACE2 Transgenic Mice. Nature 583, 830\u2013833. 10.1038/s41586-020-2312-y", "ArticleIdList": ["10.1038/s41586-020-2312-y", "32380511"]}, {"Citation": "Boiardi F., Stebbing J. (2021). Reducing Transmission of SARS-CoV-2 with Intranasal Prophylaxis. EBioMedicine 63, 103170. 10.1016/j.ebiom.2020.103170", "ArticleIdList": ["10.1016/j.ebiom.2020.103170", "PMC7750542", "33340994"]}, {"Citation": "Chan J. F.-W., Zhang A. J., Yuan S., Poon V. K.-M., Chan C. C.-S., Lee A. C.-Y., et al. (2020). Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: Implications for Disease Pathogenesis and Transmissibility. Clin. Infect. Dis. 10.1093/cid/ciaa325", "ArticleIdList": ["10.1093/cid/ciaa325", "PMC7184405", "32215622"]}, {"Citation": "Chatterjee M., van Putten J. P. M., Strijbis K. (2020). Defensive Properties of Mucin Glycoproteins during Respiratory Infections-Relevance for SARS-CoV-2. mBio 11, e02374\u201320. 10.1128/mBio.02374-20", "ArticleIdList": ["10.1128/mBio.02374-20", "PMC7663010", "33184103"]}, {"Citation": "Chen Y., Li L. (2020). SARS-CoV-2: Virus Dynamics and Host Response. Lancet Infect. Dis. 20, 515\u2013516. 10.1016/S1473-3099(20)30235-8", "ArticleIdList": ["10.1016/S1473-3099(20)30235-8", "PMC7156233", "32213336"]}, {"Citation": "Crouch E. C. (2000). Surfactant Protein-D and Pulmonary Host Defense. Respir. Res. 1, 93\u2013108. 10.1186/rr19", "ArticleIdList": ["10.1186/rr19", "PMC59549", "11667972"]}, {"Citation": "De Pellegrin M. L., Rohrhofer A., Schuster P., Schmidt B., Peterburs P., Gessner A. (2021). The Potential of Herbal Extracts to Inhibit SARS-CoV-2: a Pilot Study. Clin. Phytosci 7, 29. 10.1186/s40816-021-00264-6", "ArticleIdList": ["10.1186/s40816-021-00264-6"]}, {"Citation": "Dong Y., Dai T., Wei Y., Zhang L., Zheng M., Zhou F. (2020). A Systematic Review of SARS-CoV-2 Vaccine Candidates. Signal. Transduct Target. Ther. 5, 237\u2013314. 10.1038/s41392-020-00352-y", "ArticleIdList": ["10.1038/s41392-020-00352-y", "PMC7551521", "33051445"]}, {"Citation": "Duraipandi S., Selvakumar V. (2020). Reinventing Nano Drug Delivery Systems for Hydrophilic Active Ingredients in Ayurvedic Lipid Based Formulations Containing Poly Herbal Decoction. J. Ayurveda Integr. Med. 11, 224\u2013227. 10.1016/j.jaim.2018.01.008", "ArticleIdList": ["10.1016/j.jaim.2018.01.008", "PMC7527804", "30635246"]}, {"Citation": "Gandhi R. T., Lynch J. B., del Rio C. (2020). Mild or Moderate Covid-19. N. Engl. J. Med. 383, 1757\u20131766. null. 10.1056/NEJMcp2009249", "ArticleIdList": ["10.1056/NEJMcp2009249", "32329974"]}, {"Citation": "Garcia-Beltran W. F., Lam E. C., Denis K. S., Nitido A. D., Garcia Z. H., Hauser B. M., et al. (2021). Multiple SARS-CoV-2 Variants Escape Neutralization by Vaccine-Induced Humoral Immunity. medRxiv. 10.1101/2021.02.14.21251704", "ArticleIdList": ["10.1101/2021.02.14.21251704"]}, {"Citation": "Girija P. L. T., Sivan N. (2020). Ayurvedic Treatment of COVID-19/SARS-CoV-2: A Case Report. J. Ayurveda Integr. Med. 10.1016/j.jaim.2020.06.001", "ArticleIdList": ["10.1016/j.jaim.2020.06.001", "PMC7303645", "32680602"]}, {"Citation": "Golechha M. (2020). Time to Realise the True Potential of Ayurveda against COVID-19. Brain Behav. Immun. 87, 130\u2013131. 10.1016/j.bbi.2020.05.003", "ArticleIdList": ["10.1016/j.bbi.2020.05.003", "PMC7204691", "32389701"]}, {"Citation": "Guan W. J., Ni Z. Y., Hu Y., Liang W. H., Ou C. Q., He J. X., et al. (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 382, 1708\u20131720. 10.1056/NEJMoa2002032", "ArticleIdList": ["10.1056/NEJMoa2002032", "PMC7092819", "32109013"]}, {"Citation": "Guo R. F., Lentsch A. B., Warner R. L., Huber-Lang M., Sarma J. V., Hlaing T., et al. (2001). Regulatory Effects of Eotaxin on Acute Lung Inflammatory Injury. J. Immunol. 166, 5208\u20135218. 10.4049/jimmunol.166.8.5208", "ArticleIdList": ["10.4049/jimmunol.166.8.5208", "11290805"]}, {"Citation": "Hassan A. O., Kafai N. M., Dmitriev I. P., Fox J. M., Smith B. K., Harvey I. B., et al. (2020). A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2. Cell 183, 169\u2013184.e13. 10.1016/j.cell.2020.08.026", "ArticleIdList": ["10.1016/j.cell.2020.08.026", "PMC7437481", "32931734"]}, {"Citation": "Imai M., Iwatsuki-Horimoto K., Hatta M., Loeber S., Halfmann P. J., Nakajima N., et al. (2020). Syrian Hamsters as a Small Animal Model for SARS-CoV-2 Infection and Countermeasure Development. Proc. Natl. Acad. Sci. U S A. 117, 16587\u201316595. 10.1073/pnas.2009799117", "ArticleIdList": ["10.1073/pnas.2009799117", "PMC7368255", "32571934"]}, {"Citation": "Iwasaki A., Yang Y. (2020). The Potential Danger of Suboptimal Antibody Responses in COVID-19. Nat. Rev. Immunol. 20, 339\u2013341. 10.1038/s41577-020-0321-6", "ArticleIdList": ["10.1038/s41577-020-0321-6", "PMC7187142", "32317716"]}, {"Citation": "Jan J. T., Cheng T. R., Juang Y. P., Ma H. H., Wu Y. T., Yang W. B., et al. (2021). Identification of Existing Pharmaceuticals and Herbal Medicines as Inhibitors of SARS-CoV-2 Infection. Proc. Natl. Acad. Sci. U S A. 118, e2021579118. 10.1073/pnas.2021579118", "ArticleIdList": ["10.1073/pnas.2021579118", "PMC7865145", "33452205"]}, {"Citation": "Joshi J. A., Puthiyedath R. (2020). Outcomes of Ayurvedic Care in a COVID-19 Patient with Hypoxia - A Case Report. J. Ayurveda Integr. Med. 10.1016/j.jaim.2020.10.006", "ArticleIdList": ["10.1016/j.jaim.2020.10.006", "PMC7553124", "33071521"]}, {"Citation": "Ku M.-W., Bourgine M., Authi\u00e9 P., Lopez J., Nemirov K., Moncoq F., et al. (2021). Intranasal Vaccination with a Lentiviral Vector Protects against SARS-CoV-2 in Preclinical Animal Models. Cell Host Microbe 29, 236\u2013249.e6. 10.1016/j.chom.2020.12.010", "ArticleIdList": ["10.1016/j.chom.2020.12.010", "PMC7738935", "33357418"]}, {"Citation": "Kunzelmann K. (2021). Getting Hands on a Drug for Covid-19: Inhaled and Intranasal Niclosamide. Lancet Reg. Health Eur. 4, 100094. 10.1016/j.lanepe.2021.100094", "ArticleIdList": ["10.1016/j.lanepe.2021.100094", "PMC8041586", "33870260"]}, {"Citation": "Lee A. C., Zhang A. J., Chan J. F., Li C., Fan Z., Liu F., et al. (2020). Oral SARS-CoV-2 Inoculation Establishes Subclinical Respiratory Infection with Virus Shedding in Golden Syrian Hamsters. Cell Rep Med 1, 100121. 10.1016/j.xcrm.2020.100121", "ArticleIdList": ["10.1016/j.xcrm.2020.100121", "PMC7508015", "32984855"]}, {"Citation": "Lee D. Y. W., Li Q. Y., Liu J., Efferth T. (2021). Traditional Chinese Herbal Medicine at the Forefront Battle against COVID-19: Clinical Experience and Scientific Basis. Phytomedicine 80, 153337. 10.1016/j.phymed.2020.153337", "ArticleIdList": ["10.1016/j.phymed.2020.153337", "PMC7521884", "33221457"]}, {"Citation": "Leng L., Cao R., Ma J., Mou D., Zhu Y., Li W., et al. (2020). Pathological Features of COVID-19-Associated Lung Injury: a Preliminary Proteomics Report Based on Clinical Samples. Signal. Transduct Target. Ther. 5, 240. 10.1038/s41392-020-00355-9", "ArticleIdList": ["10.1038/s41392-020-00355-9", "PMC7557250", "33060566"]}, {"Citation": "Li S., Cheng C.-S., Zhang C., Tang G.-Y., Tan H.-Y., Chen H.-Y., et al. (2021). Edible and Herbal Plants for the Prevention and Management of COVID-19. Front. Pharmacol. 12. 10.3389/fphar.2021.656103", "ArticleIdList": ["10.3389/fphar.2021.656103", "PMC8113769", "33995078"]}, {"Citation": "Ling C. Q. (2020). Traditional Chinese Medicine Is a Resource for Drug Discovery against 2019 Novel Coronavirus (SARS-CoV-2). J. Integr. Med. 18, 87\u201388. 10.1016/j.joim.2020.02.004", "ArticleIdList": ["10.1016/j.joim.2020.02.004", "PMC7129043", "32122812"]}, {"Citation": "Malik S., Sadhu S., Elesela S., Pandey R. P., Chawla A. S., Sharma D., et al. (2017). Transcription Factor Foxo1 Is Essential for IL-9 Induction in T Helper Cells. Nat. Commun. 8, 815. 10.1038/s41467-017-00674-6", "ArticleIdList": ["10.1038/s41467-017-00674-6", "PMC5634439", "28993609"]}, {"Citation": "Mathew D., Giles J. R., Baxter A. E., Oldridge D. A., Greenplate A. R., Wu J. E., et al. (2020). Deep Immune Profiling of COVID-19 Patients Reveals Distinct Immunotypes with Therapeutic Implications. Science 369, eabc8511. 10.1126/science.abc8511", "ArticleIdList": ["10.1126/science.abc8511", "PMC7402624", "32669297"]}, {"Citation": "Matveeva T., Khafizova G., Sokornova S. (2020). In Search of Herbal Anti-SARS-Cov2 Compounds. Front. Plant Sci. 11, 589998. 10.3389/fpls.2020.589998", "ArticleIdList": ["10.3389/fpls.2020.589998", "PMC7701093", "33304368"]}, {"Citation": "Moore J. B., June C. H. (2020). Cytokine Release Syndrome in Severe COVID-19. Science 368, 473\u2013474. 10.1126/science.abb8925", "ArticleIdList": ["10.1126/science.abb8925", "32303591"]}, {"Citation": "Planas D., Bruel T., Grzelak L., Guivel-Benhassine F., Staropoli I., Porrot F., et al. (2021). Sensitivity of Infectious SARS-CoV-2 B.1.1.7 and B.1.351 Variants to Neutralizing Antibodies. Nat. Med. 27, 917\u2013924. 10.1038/s41591-021-01318-5", "ArticleIdList": ["10.1038/s41591-021-01318-5", "33772244"]}, {"Citation": "Poland G. A., Ovsyannikova I. G., Crooke S. N., Kennedy R. B. (2020a). SARS-CoV-2 Vaccine Development: Current Status. Mayo Clin. Proc. 95, 2172\u20132188. 10.1016/j.mayocp.2020.07.021", "ArticleIdList": ["10.1016/j.mayocp.2020.07.021", "PMC7392072", "33012348"]}, {"Citation": "Poland G. A., Ovsyannikova I. G., Kennedy R. B. (2020b). SARS-CoV-2 Immunity: Review and Applications to Phase 3 Vaccine Candidates. Lancet 396, 1595\u20131606. 10.1016/S0140-6736(20)32137-1", "ArticleIdList": ["10.1016/S0140-6736(20)32137-1", "PMC7553736", "33065034"]}, {"Citation": "Prabhakaran P., Ware L. B., White K. E., Cross M. T., Matthay M. A., Olman M. A. (2003). Elevated Levels of Plasminogen Activator Inhibitor-1 in Pulmonary Edema Fluid Are Associated with Mortality in Acute Lung Injury. Am. J. Physiol. Lung Cel Mol Physiol. 285, L20\u2013L28. 10.1152/ajplung.00312.2002", "ArticleIdList": ["10.1152/ajplung.00312.2002", "12730079"]}, {"Citation": "Proud P. C., Tsitoura D., Watson R. J., Chua B. Y., Aram M. J., Bewley K. R., et al. (2021). Prophylactic Intranasal Administration of a TLR2/6 Agonist Reduces Upper Respiratory Tract Viral Shedding in a SARS-CoV-2 challenge Ferret Model. EBioMedicine 63, 103153. 10.1016/j.ebiom.2020.103153", "ArticleIdList": ["10.1016/j.ebiom.2020.103153", "PMC7711201", "33279857"]}, {"Citation": "Rastogi S., Pandey D. N., Singh R. H. (2020). COVID-19 Pandemic: A Pragmatic Plan for Ayurveda Intervention. J. Ayurveda Integr. Med. S0975-9476, 30019\u2013X. 10.1016/j.jaim.2020.04.002", "ArticleIdList": ["10.1016/j.jaim.2020.04.002", "PMC7177084", "32382220"]}, {"Citation": "Rizvi Z. A., Dalal R., Sadhu S., Kumar Y., Kumar S., Gupta S. K., et al. (2021a). High-Salt Diet Mediates Interplay Between NK Cells and Gut Microbiota to Induce Potent Tumor Immunity. Sci. Adv. 7, eabg5016. 10.1126/sciadv.abg5016", "ArticleIdList": ["10.1126/sciadv.abg5016", "PMC8442882", "34516769"]}, {"Citation": "Rizvi Z. A., Dalal R., Sadhu S., Kumar Y., Srivastava T., Gupta S. K., et al. (2021b). Immunological and Cardio-Vascular Pathologies Associated with SARS-CoV-2 Infection in Golden Syrian Hamster. bioRxiv. 10.1101/2021.01.11.426080", "ArticleIdList": ["10.1101/2021.01.11.426080"]}, {"Citation": "Rizvi Z. A., Puri N., Saxena R. K. (2018). Evidence of CD1d Pathway of Lipid Antigen Presentation in Mouse Primary Lung Epithelial Cells and its Up-Regulation upon Mycobacterium Bovis BCG Infection. PLOS ONE 13, e0210116. 10.1371/journal.pone.0210116", "ArticleIdList": ["10.1371/journal.pone.0210116", "PMC6312317", "30596774"]}, {"Citation": "Sia S. F., Yan L. M., Chin A. W. H., Fung K., Choy K. T., Wong A. Y. L., et al. (2020). Pathogenesis and Transmission of SARS-CoV-2 in golden Hamsters. Nature 583, 834\u2013838. 10.1038/s41586-020-2342-5", "ArticleIdList": ["10.1038/s41586-020-2342-5", "PMC7394720", "32408338"]}, {"Citation": "Subrahmanya N. K., Patel K. S., Kori V. K., Shrikrishna R. (2013). Role of Kasahara Dashemani Vati in Kasa and Vyadhikshamatva in Children with Special Reference to Recurrent Respiratory Tract Infections. Ayu 34, 281\u2013287. 10.4103/0974-8520.123124", "ArticleIdList": ["10.4103/0974-8520.123124", "PMC3902595", "24501524"]}, {"Citation": "Supasa P., Zhou D., Dejnirattisai W., Liu C., Mentzer A. J., Ginn H. M., et al. (2021). Reduced Neutralization of SARS-CoV-2 B.1.1.7 Variant by Convalescent and Vaccine Sera. Cell 184, 2201\u2013e7. 10.1016/j.cell.2021.02.033", "ArticleIdList": ["10.1016/j.cell.2021.02.033", "PMC7891044", "33743891"]}, {"Citation": "Verity R., Okell L. C., Dorigatti I., Winskill P., Whittaker C., Imai N., et al. (2020). Estimates of the Severity of Coronavirus Disease 2019: a Model-Based Analysis. Lancet Infect. Dis. 20, 669\u2013677. 10.1016/S1473-3099(20)30243-7", "ArticleIdList": ["10.1016/S1473-3099(20)30243-7", "PMC7158570", "32240634"]}, {"Citation": "de Vries R. D., Schmitz K. S., Bovier F. T., Predella C., Khao J., Noack D., et al. (2021). Intranasal Fusion Inhibitory Lipopeptide Prevents Direct-Contact SARS-CoV-2 Transmission in Ferrets. Science 371, 1379\u20131382. 10.1126/science.abf4896", "ArticleIdList": ["10.1126/science.abf4896", "PMC8011693", "33597220"]}, {"Citation": "Wang T., Du Z., Zhu F., Cao Z., An Y., Gao Y., et al. (2020). Comorbidities and Multi-Organ Injuries in the Treatment of COVID-19. Lancet 395, e52. 10.1016/S0140-6736(20)30558-4", "ArticleIdList": ["10.1016/S0140-6736(20)30558-4", "PMC7270177", "32171074"]}, {"Citation": "Xie G., Liu Y., Yao Q., Zheng R., Zhang L., Lin J., et al. (2017). Hypoxia-induced Angiotensin II by the Lactate-chymase-dependent Mechanism Mediates Radioresistance of Hypoxic Tumor Cells. Sci. Rep. 7, 42396. 10.1038/srep42396", "ArticleIdList": ["10.1038/srep42396", "PMC5311966", "28205588"]}, {"Citation": "Xiong X., Wang P., Su K., Cho W. C., Xing Y. (2020). Chinese Herbal Medicine for Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Pharmacol. Res. 160, 105056. 10.1016/j.phrs.2020.105056", "ArticleIdList": ["10.1016/j.phrs.2020.105056", "PMC7331568", "32622723"]}, {"Citation": "Yang Y., Islam M. S., Wang J., Li Y., Chen X. (2020). Traditional Chinese Medicine in the Treatment of Patients Infected with 2019-New Coronavirus (SARS-CoV-2): A Review and Perspective. Int. J. Biol. Sci. 16, 1708\u20131717. 10.7150/ijbs.45538", "ArticleIdList": ["10.7150/ijbs.45538", "PMC7098036", "32226288"]}, {"Citation": "Zhang N., Zhao Y. D., Wang X. M. (2020). CXCL10 an Important Chemokine Associated with Cytokine Storm in COVID-19 Infected Patients. Eur. Rev. Med. Pharmacol. Sci. 24, 7497\u20137505. 10.26355/eurrev_202007_21922", "ArticleIdList": ["10.26355/eurrev_202007_21922", "32706090"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "7", "Day": "24"}, {"Year": "2021", "Month": "9", "Day": "10"}, {"Year": "2021", "Month": "11", "Day": "1", "Hour": "9", "Minute": "9"}, {"Year": "2021", "Month": "11", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "2", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "10", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["34721035", "PMC8551705", "10.3389/fphar.2021.746729", "746729"]}}], "PubmedBookArticle": []}